Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Anticancer drugs resistance

Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54 4313-4320... [Pg.92]

Durant ST, Morris MM, Bland M, et al. Dependence on RAD52 and RADI for anticancer drug resistance mediated by inactivation of mismatch repair genes. Current Biology 1999 9 51-54. [Pg.58]

Mamot, C. Drummond, D.C. Hong, K. Kirpotin, D.B. Park, J.W. Liposome-based approaches to overcome anticancer drug resistance. Drug Resistance Updates 2003, 6, 271-279. [Pg.1337]

Kaufmann, S. H., and Vaux, D. L. (2003). Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22(47), 7414-7430. [Pg.160]

Most of the 49 transporters recognize and transport a variety of xenobiotics as well as physiological substrates that include bile acids, peptides, steroid ions, and phospholipids. However, of these 49 transporters MRPl, Pgp and BGRP are the best documented for their role in conferring anticancer drug resistance and for this reason will be the focus of our discussion in this portion of the chapter. [Pg.370]

Sinha, B.K. and Mimnaugh, E.G. (1990) Free radicals and anticancer drug resistance oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. Free Radical Biol. Med. 8 567-581. [Pg.504]

Mackey JR, Baldwin SA, Young JD, Cass CE. Nucleoside transport and its significance for anticancer drug resistance. Drug Resis Updat 1998a l 310-324. [Pg.194]

Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J. Breast cancer resistance protein molecular target for anticancer drug resistance and pharmacokinetics/pharmacody-namics. Cancer Sci 2005 96 457-465. [Pg.143]

West CM, Jones T and Price P. The potential of positron-emission tomography to study anticancer-drug resistance. Nat Rev Cancer 2004 4 457-469. [Pg.636]

Anticancer drug resistance may be due to the expression of cytochromes P450 (Guengerich 1988), epoxide hydroxylase, and glutathione S-transferase (Harrison 1993, 1995). [Pg.750]

C. Metal-Induced Anticancer Drug Resistance in Cell Culture... [Pg.269]

Lazo JS, Basu A (1991) Metallothionein expression and transient resistance to electrophilic antineoplastic drugs. Semin Cancer Biol 2 267-271 Lazo JS, Sebti SM (1989) Malignant cell resistance to bleomycin to bleoymycin-group antibiotics. In Kessel D (ed) Anticancer drug resistance. CRC, Boca Raton, pp 276-279... [Pg.277]

See other pages where Anticancer drugs resistance is mentioned: [Pg.562]    [Pg.567]    [Pg.313]    [Pg.3]    [Pg.750]    [Pg.751]    [Pg.267]    [Pg.269]    [Pg.270]    [Pg.270]    [Pg.271]    [Pg.271]    [Pg.273]    [Pg.273]    [Pg.275]    [Pg.277]    [Pg.278]   
See also in sourсe #XX -- [ Pg.23 , Pg.265 ]

See also in sourсe #XX -- [ Pg.744 ]

See also in sourсe #XX -- [ Pg.267 , Pg.268 , Pg.269 , Pg.270 , Pg.271 , Pg.272 , Pg.273 , Pg.274 , Pg.275 ]



SEARCH



Anticancer agents drug resistance

Anticancer drug resistance metallothionein

Anticancer drugs

Anticancer drugs cancer chemotherapy resistance

Anticancer drugs chemotherapy resistance

Drug resistance

Drug-resistant

Enzymes, anticancer drug resistance

Induced Anticancer Drug Resistance in Cell Culture

Resistance to anticancer drugs

© 2024 chempedia.info